Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Pediatr Gastroenterol Hepatol Nutr ; 21(2): 141-146, 2018 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-29713612

RESUMEN

Nowadays, Klebsiella oxytoca is described as a causative organism for antibiotic-associated hemorrhagic colitis (AAHC). Here we report two cases of pediatric AAHC, from which K. oxytoca was cultured after starting amoxicillin-clavulanate or amoxicillin treatment. The patients developed severe abdominal pain and a large amount of bloody diarrhea. K. oxytoca was obtained in intestinal fluid culture of a boy through the colonoscopy. On the other hand, colonic tissue culture and intestinal fluid culture were negative of the other patient. K. oxytoca was detected in stool culture when he was admitted. These cases showed characteristic endoscopic findings of segmental hemorrhagic colitis, and both boys recovered spontaneously within 2-3 days after they stopped taking the antibiotics. Therefore, in children who develop relatively large amount of bloody diarrhea after antibiotic treatment, we should consider AAHC caused by K. oxytoca.

2.
Pediatr Infect Dis J ; 35(4): 457-9, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26673981

RESUMEN

Forty-three patients with Kawasaki disease who were resistant to initial intravenous immunoglobulin (IVIG) were randomized to receive either a second dose of IVIG (n = 32) or an infliximab (n = 11). With IVIG retreatment 21 patients (65.6%) responded, and with infliximab 10 patients (90.9%) responded. The infliximab group had shorter duration of fever and fewer days of hospitalization. Coronary artery outcomes and adverse events were similar.


Asunto(s)
Resistencia a Medicamentos , Infliximab/uso terapéutico , Síndrome Mucocutáneo Linfonodular/tratamiento farmacológico , Adolescente , Niño , Preescolar , Vasos Coronarios/patología , Femenino , Humanos , Inmunoglobulinas Intravenosas/uso terapéutico , Lactante , Infliximab/administración & dosificación , Infliximab/efectos adversos , Masculino , Síndrome Mucocutáneo Linfonodular/diagnóstico , Retratamiento , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...